Oral administration of the K(ATP )channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis

BACKGROUND: Multiple Sclerosis (MS) is an acquired inflammatory demyelinating disorder of the central nervous system (CNS) and is the leading cause of nontraumatic disability among young adults. Activated microglial cells are important effectors of demyelination and neurodegeneration, by secreting c...

Descripción completa

Detalles Bibliográficos
Autores principales: Virgili, Noemí, Espinosa-Parrilla, Juan F, Mancera, Pilar, Pastén-Zamorano, Andrea, Gimeno-Bayon, Javier, Rodríguez, Manuel J, Mahy, Nicole, Pugliese, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215935/
https://www.ncbi.nlm.nih.gov/pubmed/22047130
http://dx.doi.org/10.1186/1742-2094-8-149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215935/
https://www.ncbi.nlm.nih.gov/pubmed/22047130
http://dx.doi.org/10.1186/1742-2094-8-149

Ejemplares similares